0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(2):928–935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1518 Aurora B Overexpression Associates with the Thyroid Carcinoma Undifferentiated Phe
暂无分享,去创建一个
P. Chieffi | A. Fusco | G. Troncone | G. Portella | P. Laccetti | P. Pallante | R. Sorrentino | S. Libertini | L. Palombini | S. Linardopoulos | V. Bavetsias | D. Spalletti-Cernia
[1] L. Montagnier,et al. AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS. , 1964, Virology.
[2] B. Estour,et al. Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1) , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.
[3] M. Santoro,et al. The Kirsten murine sarcoma virus induces rat thyroid carcinomas in vivo. , 1989, Oncogene.
[4] L. Sobin,et al. The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.
[5] M. Santoro,et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas , 1990, Cell.
[6] B. Caillou,et al. Presence of mutations in all three ras genes in human thyroid tumors. , 1990, Oncogene.
[7] T. Sugimura,et al. cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. , 1990, Biochemical and biophysical research communications.
[8] M. Parmentier,et al. Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. , 1991, Endocrinology.
[9] T. Seyama,et al. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. , 1992, Cancer research.
[10] T. Oyama,et al. Overexpression of p53 as a Possible Prognostic Factor in Human Thyroid Carcinoma , 1993, The American journal of surgical pathology.
[11] J. Fagin,et al. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. , 1993, The Journal of clinical investigation.
[12] M. Parmentier,et al. Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene. , 1995, Oncogene.
[13] G. Fontanini,et al. Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1. , 1997, The Journal of clinical endocrinology and metabolism.
[14] D. Wynford‐Thomas,et al. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. , 1997, Hormone research.
[15] Jian Kuang,et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.
[16] H. Katayama,et al. Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. , 1998, Cancer research.
[17] D. Powell,et al. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. , 1998, Cancer research.
[18] Brian Schryver,et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.
[19] H. Katayama,et al. Mitotic kinase expression and colorectal cancer progression. , 1999, Journal of the National Cancer Institute.
[20] B. Spiegelman,et al. PAX8-PPARγ1 Fusion in Oncogene Human Thyroid Carcinoma , 2000 .
[21] C. J. Chen,et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. , 2000, Science.
[22] B. Bass. Double-Stranded RNA as a Template for Gene Silencing , 2000, Cell.
[23] Richard R. Adams,et al. Essential Roles of Drosophila Inner Centromere Protein (Incenp) and Aurora B in Histone H3 Phosphorylation, Metaphase Chromosome Alignment, Kinetochore Disjunction, and Chromosome Segregation , 2001, The Journal of cell biology.
[24] Erich A. Nigg,et al. Cell division: Mitotic kinases as regulators of cell division and its checkpoints , 2001, Nature Reviews Molecular Cell Biology.
[25] P. Jallepalli,et al. Chromosome segregation and cancer: cutting through the mystery , 2001, Nature Reviews Cancer.
[26] A. Fire,et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] G. Fuller,et al. RET Oncogene Activation in Papillary Thyroid Carcinoma , 2001, Advances in anatomic pathology.
[28] Y. Miyoshi,et al. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers , 2001, International journal of cancer.
[29] W. Earnshaw,et al. Chromosomal passengers and the (aurora) ABCs of mitosis. , 2001, Trends in cell biology.
[30] C. Moskaluk,et al. Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. , 2001, Gastroenterology.
[31] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[32] D. Stoler,et al. Genomic instability measurement in the diagnosis of thyroid neoplasms , 2002, Head & neck.
[33] J. Fagin,et al. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1 , 2002, Clinical endocrinology.
[34] Yu-Li Wang,et al. The Kinase Activity of Aurora B Is Required for Kinetochore-Microtubule Interactions during Mitosis , 2002, Current Biology.
[35] Stéphanie Dutertre,et al. On the role of aurora-A in centrosome function , 2002, Oncogene.
[36] H. Katayama,et al. Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. , 2002, Cancer research.
[37] M. Jantsch,et al. The Aurora B Kinase AIR-2 Regulates Kinetochores during Mitosis and Is Required for Separation of Homologous Chromosomes during Meiosis , 2002, Current Biology.
[38] M. Nikiforova,et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. , 2003, The Journal of clinical endocrinology and metabolism.
[39] P. Gattuso,et al. Genomic DNA Extraction and PCR Amplification of Exon 15 of the BRAF Gene and Exons 1 and 2 of the NRAS Gene , 2003 .
[40] H. Friess,et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] J. Swedlow,et al. Mitotic mechanics: the auroras come into view. , 2003, Current opinion in cell biology.
[42] Yuri E Nikiforov,et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.
[43] P. Ladenson,et al. BRAF mutation in papillary thyroid carcinoma. , 2003, Journal of the National Cancer Institute.
[44] O. Sieber,et al. Genomic instability — the engine of tumorigenesis? , 2003, Nature Reviews Cancer.
[45] Shinichi Suzuki,et al. BRAF mutations in papillary carcinomas of the thyroid , 2003, Oncogene.
[46] Hiroki Nagase,et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human , 2003, Nature Genetics.
[47] S. Fujita,et al. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma , 2003, British journal of haematology.
[48] Stephen S. Taylor,et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores , 2003, The Journal of cell biology.
[49] Domenico Coppola,et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] P. Chieffi,et al. Aurora B expression in normal testis and seminomas. , 2004, The Journal of endocrinology.